Stock listing
NASDAQ:INBX Inhibrx Biosciences, Inc. Stock
Home listing (NASDAQ) of Inhibrx Biosciences, Inc.
Follow Inhibrx Biosciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:INBX
$89.79 USD -0.04 (-0.0%)
Close on Oct 19, 2026
- Day range
- $88.21 – $92.98 USDOct 19, 2026
- Volume
- 156,060 sharesOct 19, 2026
- Market value
- $1.32B USDAt the close on Oct 19, 2026 · price × 14.72M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:INBX · Home | $89.79 USD | -0.04 (0.0%) | 156,060 | $90.43 | $92.98 | $88.21 | $89.83 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:INBX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $89.79 | -0.04 | 0.0% | $90.43 | $92.98 | $88.21 | 156,060 | |
| $89.83 | -0.67 | -0.7% | $89.83 | $90.72 | $87.73 | 145,923 | |
| $90.50 | +5.24 | +6.1% | $87.60 | $91.68 | $87.20 | 226,371 | |
| $85.26 | -1.82 | -2.1% | $86.23 | $87.36 | $83.61 | 245,012 | |
| $87.08 | -3.45 | -3.8% | $90.11 | $92.46 | $85.80 | 271,309 | |
| $90.53 | -4.48 | -4.7% | $94.03 | $96.10 | $90.00 | 214,035 | |
| $95.01 | +2.25 | +2.4% | $92.70 | $95.81 | $92.70 | 86,819 | |
| $92.76 | -0.60 | -0.6% | $93.14 | $93.28 | $90.15 | 208,038 | |
| $93.36 | -0.05 | -0.1% | $92.02 | $96.71 | $90.66 | 223,779 | |
| $93.41 | -1.15 | -1.2% | $95.52 | $96.96 | $92.60 | 169,400 | |
| $94.56 | -2.43 | -2.5% | $97.56 | $98.51 | $94.18 | 206,900 | |
| $96.99 | -0.94 | -1.0% | $99.30 | $100.13 | $96.07 | 201,400 | |
| $97.93 | -2.15 | -2.1% | $100.71 | $102.16 | $97.58 | 216,600 | |
| $100.08 | -4.75 | -4.5% | $105.67 | $106.94 | $100.08 | 389,500 | |
| $104.83 | +3.12 | +3.1% | $105.31 | $107.90 | $102.51 | 240,900 | |
| $101.71 | +2.10 | +2.1% | $98.69 | $104.55 | $98.51 | 188,100 | |
| $99.61 | -0.79 | -0.8% | $101.29 | $101.29 | $98.09 | 158,700 | |
| $100.40 | +0.07 | +0.1% | $102.38 | $104.49 | $99.53 | 285,700 | |
| $100.33 | -10.34 | -9.3% | $110.12 | $110.88 | $98.56 | 375,300 | |
| $110.67 | -1.37 | -1.2% | $112.45 | $117.14 | $109.05 | 292,100 | |
| $112.04 | +2.69 | +2.5% | $112.69 | $113.19 | $108.95 | 249,100 | |
| $109.35 | +4.62 | +4.4% | $106.45 | $110.41 | $105.04 | 483,400 | |
| $104.73 | +2.96 | +2.9% | $103.73 | $108.00 | $103.73 | 216,600 | |
| $101.77 | -3.84 | -3.6% | $105.61 | $106.44 | $99.06 | 363,500 | |
| $105.61 | -4.86 | -4.4% | $109.44 | $109.44 | $104.85 | 251,600 | |
| $110.47 | +1.20 | +1.1% | $109.10 | $111.44 | $104.90 | 240,000 | |
| $109.27 | -2.15 | -1.9% | $113.00 | $115.11 | $108.93 | 211,000 | |
| $111.42 | -1.44 | -1.3% | $109.23 | $113.95 | $107.22 | 313,900 | |
| $112.86 | -1.48 | -1.3% | $117.38 | $128.54 | $112.03 | 677,800 | |
| $114.34 | -6.83 | -5.6% | $117.22 | $120.18 | $94.00 | 1,672,200 | |
| $121.17 | -1.09 | -0.9% | $121.04 | $124.19 | $120.48 | 194,600 | |
| $122.26 | -2.71 | -2.2% | $125.20 | $126.00 | $120.17 | 151,700 | |
| $124.97 | +0.31 | +0.2% | $125.61 | $127.75 | $121.25 | 189,900 | |
| $124.66 | -2.04 | -1.6% | $124.98 | $129.88 | $120.62 | 275,600 | |
| $126.70 | +3.29 | +2.7% | $123.39 | $128.87 | $121.59 | 389,000 | |
| $123.41 | -0.52 | -0.4% | $123.80 | $126.04 | $119.38 | 241,500 | |
| $123.93 | -1.41 | -1.1% | $124.27 | $127.34 | $122.36 | 310,900 | |
| $125.34 | +2.62 | +2.1% | $123.00 | $131.01 | $119.44 | 302,900 | |
| $122.72 | +17.78 | +16.9% | $105.50 | $126.50 | $104.71 | 510,600 | |
| $104.94 | +1.31 | +1.3% | $105.00 | $105.14 | $94.20 | 373,500 | |
| $103.63 | +4.48 | +4.5% | $100.76 | $105.65 | $99.05 | 220,700 | |
| $99.15 | -2.33 | -2.3% | $98.65 | $102.50 | $96.57 | 351,500 | |
| $101.48 | +6.86 | +7.3% | $96.01 | $102.25 | $95.27 | 310,700 | |
| $94.62 | +2.61 | +2.8% | $89.83 | $94.89 | $89.00 | 311,200 | |
| $92.01 | +3.64 | +4.1% | $87.06 | $92.99 | $85.06 | 231,700 | |
| $88.37 | -8.64 | -8.9% | $91.80 | $96.06 | $87.01 | 268,300 | |
| $97.01 | -1.35 | -1.4% | $99.95 | $101.00 | $94.32 | 251,200 | |
| $98.36 | +5.98 | +6.5% | $93.40 | $98.85 | $89.38 | 158,600 | |
| $92.38 | -0.73 | -0.8% | $93.41 | $94.41 | $90.97 | 260,026 | |
| $93.11 | +4.45 | +5.0% | $88.34 | $94.07 | $88.05 | 337,144 | |
| $88.66 | +2.87 | +3.3% | $86.78 | $89.28 | $80.42 | 407,700 | |
| $85.79 | +1.90 | +2.3% | $83.83 | $87.74 | $83.83 | 87,700 | |
| $83.89 | +0.36 | +0.4% | $84.05 | $85.75 | $82.58 | 142,100 | |
| $83.53 | +0.81 | +1.0% | $84.84 | $85.85 | $82.97 | 217,700 | |
| $82.72 | +0.67 | +0.8% | $81.86 | $83.20 | $80.50 | 134,500 | |
| $82.05 | -2.68 | -3.2% | $85.63 | $85.63 | $80.35 | 109,100 | |
| $84.73 | +5.48 | +6.9% | $81.01 | $85.47 | $79.67 | 275,500 | |
| $79.25 | -0.43 | -0.5% | $79.93 | $81.10 | $77.51 | 214,200 | |
| $79.68 | -2.77 | -3.4% | $82.36 | $84.10 | $78.07 | 185,900 | |
| $82.45 | +0.90 | +1.1% | $82.61 | $86.14 | $81.01 | 266,000 | |
| $81.55 | -3.45 | -4.1% | $86.00 | $86.00 | $81.54 | 164,700 | |
| $85.00 | -0.92 | -1.1% | $83.98 | $87.30 | $83.50 | 165,500 | |
| $85.92 | -1.69 | -1.9% | $85.92 | $87.50 | $85.28 | 150,500 | |
| $87.61 | +3.52 | +4.2% | $85.00 | $90.00 | $83.43 | 136,900 | |
| $84.09 | -3.30 | -3.8% | $87.53 | $88.38 | $83.22 | 352,500 |
- Ticker
- NASDAQ:INBX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 13, 2026
Inhibrx Announces Participation in Upcoming Scientific Conferences
Latest deck · Sep 28, 2026
Investor Presentation (September 2026)
Investor deck · 44 slides
Latest news
Inhibrx Announces Participation in Upcoming Scientific Conferences
Oct 13, 2026
Closed $85.26 (-2.1%) on Oct 14, 2026
Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study
Sep 8, 2026
Closed $114.34 (-5.6%) on Sep 8, 2026
Inhibrx To Host Webcast Presentation to Provide Primary Endpoint Results for INBRX-106 Phase 2 First-Line HNSCC Study
Sep 4, 2026
Closed $114.34 (-5.6%) on Sep 8, 2026
Inhibrx Reports Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $88.37 (-8.9%) on Aug 14, 2026
Inhibrx Biosciences Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million
Jul 16, 2026
Closed $89.07 (-2.4%) on Jul 16, 2026
Financings
Term C Loan with warrants
Jul 16, 2026
Closed: US$100M raised · Warrants at US$93.21 for 120 months
Buyers: Oxford Finance LLC (funded the $100.0 million Term C Loan and received warrants to purchase 21,457 shares)
Use of proceeds: Advancing the ozekibart (INBRX-109) and INBRX-106 programs
Decks
Investor Presentation (September 2026)
Investor deck · 44 slides · Sep 28, 2026
Investor Presentation (September 2026)
Investor deck · 40 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 26 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 24 slides · September 2026
Inhibrx Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 24 in all · newest Oct 13, 2026 · oldest 2024
- Decks
- 32 decks · latest Sep 28, 2026
Where Inhibrx Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:INBX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:INBX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Inhibrx Biosciences, Inc.